Sp196
METHYLATED DNA BIOMARKERS IN PANCREATIC JUICE FOR PANCREATIC CANCER DETECTION
Date
May 6, 2023
Explore related products in the following collection:
Society: AGA
A translational symposium that focuses on the evolving role of artificial intelligence and machine learning in early detection of pancreatic cancer, genetic testing and novel molecular diagnostic bio-markers and recent advances in digital tools that can be applied to enhance early detection and improve care of high-risk individuals.
A translational symposium that focuses on the evolving role of artificial intelligence and machine learning in early detection of pancreatic cancer, genetic testing and novel molecular diagnostic bio-markers and recent advances in digital tools that can be applied to enhance early detection and improve care of high-risk individuals.
Presenter
Mayo Clinic Minnesota
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
MOLECULAR DETECTION OF PANCREATIC NEUROENDOCRINE TUMORS USING PLASMA METHYLATED DNA MARKERS
BACKGROUND: Colonic polyposis, which is a risk factor for colorectal cancer (CRC), can be driven by a pathogenic variant in a polyposis gene. However, in many cases germline genetic testing is negative, leaving the cause of the polyposis unknown…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
INTRODUCTION
SOCIETY: AGA
